Industry reports
Editor highlights

Publication dates

All regions

Rheumatoid Arthritis Research Reports, April 2014

You might be interested in: disease testing, therapeutics, medical equipment, more »


 

1-20 of about 8 900 reports for Rheumatoid Arthritis
Active Biotech AB (ACTI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Active Biotech AB (ACTI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • March 2014
  • by Global Data

... Of systemic sclerosis and rhudextm, which is in development for the treatment of rheumatoid arthritis. Active biotech has licensing agreements with teva, ipsen and medigene ag. Active biotech is headquartered ...

Rheumatoid Arthritis Partnering 2009-2014

Rheumatoid Arthritis Partnering 2009-2014

  • $ 1 795
  • Industry report
  • March 2014
  • by Currentpartnering

... Where press releases do not. This data driven report contains over 200 links to online copies of actual rheumatoid arthritis deals and contract documents as submitted to the securities ...

Musculoskeletal Partnering Terms and Agreements

Musculoskeletal Partnering Terms and Agreements

  • $ 2 995
  • Industry report
  • March 2014
  • by Currentpartnering

... Indication musculoskeletal arthritis osteoarthritis psoriatic arthritis rheumatoid arthritis bone fracture hip gout knee ...

Rheumatoid Arthritis - Pipeline Review, H1 2014

Rheumatoid Arthritis - Pipeline Review, H1 2014

  • $ 2 500
  • Industry report
  • February 2014
  • by Global Markets Direct

... Scope- the report provides a snapshot of the global therapeutic landscape of rheumatoid arthritis- the report reviews key pipeline products under drug profile section which includes, product description, mo ...

Product and Pipeline Assessment of the Global Orphan Drugs Market

Product and Pipeline Assessment of the Global Orphan Drugs Market

  • $ 5 000
  • Industry report
  • February 2014
  • by Frost & Sullivan

... Juvenile rheumatoid arthritis, pulmonary fibrosis, and primary brain tumors. Remicade, a popular anti-inflammatory drug used in multiple indications, was approved for crohn's disease when that condition ...

KAHR medical Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

KAHR medical Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • February 2014
  • by Global Data

... Such as ctla-4 and fasl, which is used for the treatment of psoriasis and rheumatoid arthritis. The company uses signal converter proteins technology. Kahr is headquartered in jerusalem, israel ...

Nitec Pharma AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Nitec Pharma AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • February 2014
  • by Global Data

... And commercialization of innovative treatments for chronic inflammation and pain-related diseases. The company markets lodotra, a circadian cytokine modulator as its lead product for the treatment of rheumatoid arthritis ...

VLST Corporation, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

VLST Corporation, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • February 2014
  • by Global Data

... Kine to treat autoimmune disease. The company also provides discovery platform, which is applied to treat rheumatoid arthritis, multiple sclerosis, crohn's disease, lupus, and vasculitis. Its antikine is also ...

Morphotek, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Morphotek, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • February 2014
  • by Global Data

... Nonsmall cell lung cancer, melanoma, colorectal carcinoma, sarcoma, mesothelioma, and rheumatoid arthritis. It has partnerships with many corporations, research organizations, and academic centers ...

SkyePharma PLC (SKP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

SkyePharma PLC (SKP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Industry report
  • February 2014
  • by Global Data

... Of hypertension; diclofenac-ratiopharm-uno, designed to treat pain/inflammation; lodotra/rayos, indicated for the treatment of rheumatoid arthritis; coruno, designed to treat angina; xatral od, developed against ...


» Read our Company Profiles

1 Companies for Rheumatoid Arthritis

Johnson and Johnson

United States

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.